An FDA advocacy group is stumped as to how FDA will resume operations and receive funding from Congress after President Donald Trump agreed on Friday (Jan. 25) to reopen the federal government for three weeks. Though the three weeks offers a window through which Congress could pass an appropriations bill that would provide FDA with a funding boost for fiscal 2019, lawmakers might only be able to pass a continuing resolution, the Alliance for a Stronger FDA wrote in its...